Germany - DAAD Tokyo

Document technical information

Format ppt
Size 1.1 MB
First found May 22, 2018

Document content analysis

Category Also themed
Language
Type
not defined
Concepts
no text concepts found

Persons

Gustave Eiffel
Gustave Eiffel

wikipedia, lookup

Organizations

Places

Transcript

Why Germany?
Warum Deutschland?
Dr Nicole Hilbrandt
DAAD
DAAD Fachtage 2007
Osaka - October 6 2007
Structure of the German Research Landscape
Basic research
Max Planck
Society
Universities
Leibniz
Association
Applied sciences
Fraunhofer
Society
Helmholtz
Association
Industry
AiF
2
Current developments in Germany
High-tech strategy
Excellence initiative
 Graduate schools
 Excellence clusters
 Institutional strategies
Internationalization
 International Research Training Groups/Schools, IMPRS
 Emmy Noether Programme etc.
 Working permits
Improved career path
 Tenure track option, Junior professorship etc.
 Age limit of fellowships
 GAIN
3
Implications of the Lisbon Process
Europe (current: 1.84% of GDP)
 Increase of the annual budget by €100 billion
 700,000 additional scientists
Germany (current: 2.51% of GDP)
 Increase of the annual budget by €10 billion
 70,000 additional scientists
bright perspective for bright people
4
Investment in research and development
 third-highest investments worldwide
 highest investments in Europe
€ billions
250
200
150
100
50
0
251
117
56
36
30
201
USA
Japan
Germany
France
GB
EU 27
Source: Eurostat, PM 12.Januar 2007
5
Investment in research and development
US $ per capita
1.000
800
600
400
200
0
940
818
655
587
489
USA
Japan
Germany
France
GB
Per capita investment in R&D
Source: Federal Government Report on Research 2004; calculated purchasing power
6
Investment in research and development
%
4
3
2
1
0
3,86
3,48
3,18
2,68
2,51
2,13
1,84
1,73
Sweden
Finland
Japan
USA
Germany
France
EU 27
GB
Proportion of R&D expenditure relative to GDP (2005)
Source: Federal Government Report on Research 2006
7
Worldwide research capacity
10
FIN
Land
Researchers (total)
USA
1,261,227
Japan
8
6
675,330
Germany
264,721
France
186,420
UK
157,662
EU
1,178,237
in 2003
4
JP
USA
D F
UK EU
2
Finnland
Japan
USA
Deutschland
Frankreich
UK
EU
0
Forscher
Researchers
per 1000 inhabitants
Source: EU - Towards a European Research Area. Key Figures 2005
8
Research funding per researcher
In €1000 per researcher
350
300
250
200
150
100
50
0
266
227
212
199
182
180
171
145
CH
S
J
D
USA
F
EU 15
GB
Source: Key Figures 2003-2004
9
Scientific qualifications
30,0
20,0
10,0
0,0
32
19
16
16
9
Germany
GB
France
USA
Japan
Newly acquired doctoral degrees per 100,000 inhabitants in 2000
Source: PSA target metrics for the UK Research Base
10
Scientific quality
Publications in %
40
30
20
10
0
38,31
31,1
9,55
8,49
8,4
6,08
EU 25
USA
Japan
GB
Germany
France
Source: Key Figures 2005
11
Research in physics and mechanical engineering
12
12
10
10
8
8
6
6
4
4
2
2
0
10,6
8,9
7,8
6,2
Germany
Japan
GB
France
Citations in international publications
in the field of physics
in % in 2002 (not incl. USA)
0
10,0
10,0
6,7
6,0
Germany
Japan
GB
France
Citations in international publications
in the field of mechanical
engineering in % in 2002 (not
incl. USA)
Source: PSA target metrics for the UK Research Base
12
Research in biology and the environment
12
14,0
10
12,0
10,0
8
8,0
6
6,0
4
4,0
2
0
10,8
8,8
6,6
5,6
GB
Germany
Japan
France
Citations in international publications
in the field of biology
in % in 2002 (not incl. USA)
2,0
0,0
11,6
8,7
5,8
3,0
GB
Germany
France
Japan
Citations in international publications
in the field of environment
in % in 2002 (not incl. USA)
Source: PSA target metrics for the UK Research Base
13
Research in medicine and mathematics
12
12
10
10
8
8
6
6
4
4
2
2
0
10,2
7,4
4,8
4,8
GB
Germany
France
Japan
Citations in international publications
in the field of medicine
in % in 2002 (not incl. USA)
0
10,0
8,6
6,6
4,1
France
GB
Germany
Japan
Citations in international publications
in the field of mathematics in %
in 2002 (not incl. USA)
Source: PSA target metrics for the UK Research Base
14
Nobel Prizes 1901 - 2005
 783 Nobel Prizes in total
 77 Nobel Prizes to German scientists
300
250
200
150
13
pa
n
la
nd
20
itz
er
ed
en
Sw
Fr
an
ce
Ge
30
Ja
50
77
rm
an
y
99
GB
0
289
US
A
50
Sw
100
Source: www.nofestibel.com
15
The most active research companies in the EU
€ billion
6,00
5,00
4,00
3,00
2,00
1,00
0,00
DaimlerChrysler
Siemens
GlaxoSmithKline
Volkswagen
Sanofi-Aventis
Nokia
BMW
Robert Bosch
AstraZeneca
Ericsson
blue: German companies
Source: Scoreboard 2006
16
European patents by country of origin
16.000
12.000
(25,15%)
(22,38%)
8.000
(17,15%)
(8,01%)
4.000
0
(4,47%)
15.088
13.429
10.291
4.805
2.679
USA
Germany
Japan
France
GB
European patents 2003
( ) = share of the total amount of patents
Source: EPO
17
Triade patents by country of origin
In %
35
30
25
20
15
10
5
0
34
32
27
13,2
5
4
USA
EU 25
Japan
Germany
France
GB
worldwide patents (triade) 2000
Source: EPO
18
Worldwide patents - country of origin
USA
25 %
Other countries < 7%
Germany
Japan
19%
17%
Rest of the
world
Leading research areas:
• Automobile research
• Nanotechnology, Biotechnology
• Environment and energy research
Germany is world No. 2 and No. 1 in Europe!
Source: EPO, 2005
19
Summary
 High quality science (publications) and a high number of patent
applications,
 a unique infrastructure of high-output research institutions and
strong research companies (highly differentiated research system),
 highly-qualified personnel,
 high-level of research investment and companies that invest
substantially in research and development,
make Germany the
No. 1 research and innovation location in Europe.
20
Integration into research policy
High-tech strategy
Intern.
Initiative
Promoting
Research in Germany
DAAD
21
Forecast of the 10 most attractive R&D countries from
2005-2009
% of the answers
70
60
50
40
30
Forecast: most
attractive R&D
countries 2005-2009
20
Canada
Netherlands
Germany
France
Russia
GB
Japan
India
USA
0
China
10
Source: UNCTAD, survey 2005
22
Many thanks.
For more information
www.research-in-germany.de
23
German Nobel Prize winners
1991
1991
1994
Erwin Neher
Bert Sakmann
Reinhard Selten
MPI Göttingen
MPI Heidelberg
University of Bonn
Medicine
Medicine
Business
1995
Christiane
Nüsslein-Vollhard
MPI Tübingen
1997
Horst L. Störmer
Columbia
University
1999
Medicine
Physics
2000
Herbert Kroemer
University of
California
2001
2005
Wolfgang Ketterle
Theodor W.
Hänsch
Physics
Physics
MIT Cambridge
Günther Grass
Literature
MPI München
Physics
24
Ratio of industrial to federal investment
%
100
80
60
Other
State
Industry
Figures are standardised to 100%
40
20
Lu
xe
m
bo
ur
Ja g
p
S w an
ed
e
Fi n
nl
G and
er
m
a
B e ny
lg
iu
m
Ire
la
nd
U
SA
EU
25
0
Source: Key Figures 2005
25

Similar documents

×

Report this document